Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |